# OnCo record car001 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/car001/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "car001" ;
  schema:name "CAR001"@en ;
  schema:alternateName "HLA-G-CAR.BiTE allogeneic gamma delta T cells"@en ;
  schema:description "CAR001 is an off-the-shelf immune cell therapy from Ever Supreme Bio Technology, made from donor gamma delta T cells. It is in an early trial in solid tumours, and the FDA has given it orphan drug status for malignant glioma."@en ;
  schema:url <https://onco.cc/drugs/car001/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://en.ever-supreme.com.tw/news_detail/41>, <https://clinicaltrials.gov/study/NCT06150885>, <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1176726> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "orphan-designation" ;
  onco:modality "Allogeneic CAR gamma delta T-cell therapy" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/gamma-delta-t-cell-therapy/> ;
  onco:targets <https://onco.cc/targets/pdl1/> ;
  onco:companies <https://onco.cc/companies/ever-supreme-bio-technology/> ;
  onco:trials <https://onco.cc/trials/nct06150885/> .